A Clinical Trial to Investigate the Efficacy and Safety of Evogliptin

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This is a randomized, double-blind, placebo-controlled, phase III clinical trial to investigate the efficacy and safety of evogliptin after oral administration in patients with type 2 diabetes who have inadequate glycemic control on diet and exercise.
Epistemonikos ID: 4aed21300dfe28ecde084890dda497a4c116b87c
First added on: May 17, 2024